BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7972859)

  • 1. Iron status in schizophrenic patients with acute neuroleptic-induced dystonic reactions.
    Spina E; Ancione M; Di Rosa AE; Artemisia A; Natoli C; Caputi AP
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Sep; 18(5):891-8. PubMed ID: 7972859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum iron and transferrin in acute neuroleptic induced akathisia.
    O'Loughlin V; Dickie AC; Ebmeier KP
    J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):363-4. PubMed ID: 1676049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients.
    Csernansky JG; Kaplan J; Holman CA; Hollister LE
    Psychopharmacology (Berl); 1983; 81(2):115-8. PubMed ID: 6138793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low serum iron in patients with neuroleptic-induced akathisia and dystonia under antipsychotic drug treatment.
    Horiguchi J
    Acta Psychiatr Scand; 1991 Sep; 84(3):301-3. PubMed ID: 1683097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tardive dyskinesia and serum iron indices.
    Wirshing DA; Bartzokis G; Pierre JM; Wirshing WC; Sun A; Tishler TA; Marder SR
    Biol Psychiatry; 1998 Sep; 44(6):493-8. PubMed ID: 9777182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum iron and ferritin in acute neuroleptic akathisia.
    Hofmann M; Seifritz E; Botschev C; Kräuchi K; Müller-Spahn F
    Psychiatry Res; 2000 Apr; 93(3):201-7. PubMed ID: 10760378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute drug-induced akathisia is not associated with low serum iron status.
    Sachdev P; Loneragan C
    Psychopharmacology (Berl); 1991; 103(1):138-9. PubMed ID: 1672456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic-induced extrapyramidal symptoms and serum calcium levels. Results of a pilot study.
    Kuny S; Binswanger U
    Neuropsychobiology; 1989; 21(2):67-70. PubMed ID: 2575718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive dyskinesia and iron status.
    Chong SA; Mythily ; Remington G
    J Clin Psychopharmacol; 2004 Apr; 24(2):235-6. PubMed ID: 15206676
    [No Abstract]   [Full Text] [Related]  

  • 10. Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia.
    Nasrallah HA; Churchill CM; Hamdan-Allan GA
    Am J Psychiatry; 1988 Nov; 145(11):1455-6. PubMed ID: 2903686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low plasma iron status and akathisia.
    Barton A; Bowie J; Ebmeier K
    J Neurol Neurosurg Psychiatry; 1990 Aug; 53(8):671-4. PubMed ID: 1976763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effects of antipsychotic drugs.
    Malhotra AK; Litman RE; Pickar D
    Drug Saf; 1993 Dec; 9(6):429-36. PubMed ID: 7907481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum iron abnormalities in neuroleptic-induced akathisia in schizophrenic patients.
    Soni SD; Tench D; Routledge RC
    Br J Psychiatry; 1993 Nov; 163():669-72. PubMed ID: 7905347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.
    Sramek JJ; Simpson GM; Morrison RL; Heiser JF
    J Clin Psychiatry; 1986 Jun; 47(6):305-9. PubMed ID: 2872206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of neuroleptic-induced dystonia in mania and schizophrenia.
    Khanna R; Das A; Damodaran SS
    Am J Psychiatry; 1992 Apr; 149(4):511-3. PubMed ID: 1348162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pharmacological therapy on anthropometric and biochemical status of male and female institutionalized psychiatric patients.
    Martínez JA; Velasco JJ; Urbistondo MD
    J Am Coll Nutr; 1994 Apr; 13(2):192-7. PubMed ID: 7911810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinsonism induced by atypical neuroleptics in a patient with severe iron deficiency.
    Yoshida T; Suzuki G; Nibuya M; Sano SY; Nomura S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb; 24(1):29-31. PubMed ID: 15027328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA; Mythily ; Lum A; Huak CY; Kane J
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.